Lack of the trans-receptor mechanism of HIV-1 infection: CD4- and coreceptor-independent incorporation of HIV-1-resistant cells into syncytia induced by HIV-1

Microbes and Infection

Volumn 14, Issue 4, 2012, Pages 357-368

  Hoque, Sheikh Ariful ^a   Ohtsuki, Takahiro ^a   Tatsumi, Masashi ^b   Shimizu, Nobuaki ^a   Islam, Salequl ^a   Jinno Oue, Atsushi ^a   Hoshino, Hiroo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

CCR5 and CXCR4; CD4 receptor; Cell fusion; Coreceptors; HIV 1; Soluble CD4; Syncytia

Indexed keywords

BETA1 INTEGRIN; CADHERIN; CADHERIN 11; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CONNEXIN 43; HUMAN IMMUNODEFICIENCY VIRUS 1 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; MESSENGER RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VIRUS ENVELOPE PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SYNCYTIUM; TIME; TRANSACTIVATION; VIRUS PATHOGENESIS; VIRUS RESISTANCE; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD4; CELL ADHESION MOLECULES; CELL LINE; GENE SILENCING; GIANT CELLS; HIV-1; HUMANS; MICE; RECEPTORS, CCR5; RECEPTORS, HIV; RNA, SMALL INTERFERING; STAINING AND LABELING;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84857992812     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.11.005     Document Type: Article

References (46)

1. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R.E., Hill C.M., Davis C.B., Peiper S.C., Schall T.J., Littman D.R., Landau N.R. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
2. Dalgleish A.G., Beverley P.C., Clapham P.R., Crawford D.H., Greaves M.F., Weiss R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312:763-767.
3. Dobrowsky T.M., Zhou Y., Sun S.X., Siliciano R.F., Wirtz D. Monitoring early fusion dynamics of human immunodeficiency virus type 1 at single-molecule resolution. J. Virol. 2008, 82:7022-7033.
4. van Montfort T., Thomas A.A., Pollakis G., Paxton W.A. Dendritic cells preferentially transfer CXCR4-using human immunodeficiency virus type 1 variants to CD4+ T lymphocytes in trans. J. Virol. 2008, 82:7886-7896.
5. Huang W., Toma J., Fransen S., Stawiski E., Reeves J.D., Whitcomb J.M., Parkin N., Petropoulos C.J. Coreceptor tropism can be influenced by amino acid substitutions in the gp41 transmembrane subunit of human immunodeficiency virus type 1 envelope protein. J. Virol. 2008, 82:5584-5593.
6. Huerta L., Lamoyi E., Baez-Saldana A., Larralde C. Human immunodeficiency virus envelope-dependent cell-cell fusion: a quantitative fluorescence cytometric assay. Cytometry 2002, 47:100-106.
7. Salzwedel K., Smith E.D., Dey B., Berger E.A. Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120. J. Virol. 2000, 74:326-333.
8. Wyatt R., Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998, 280:1884-1888.
9. Haim H., Si Z., Madani N., Wang L., Courter J.R., Princiotto A., Kassa A., DeGrace M., McGee-Estrada K., Mefford M., Gabuzda D., Smith A.B., Sodroski J. Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state. PLoS Pathog. 2009, 5. e1000360.
10. Esser U., Speck R.F., Deen K.C., Atchison R.E., Sweet R., Goldsmith M.A. Molecular function of the CD4 D1 domain in coreceptor-mediated entry by HIV type 1. AIDS Res. Hum. Retroviruses 2000, 16:1845-1854.
11. Speck R.F., Esser U., Penn M.L., Eckstein D.A., Pulliam L., Chan S.Y., Goldsmith M.A. A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1. Curr. Biol. 1999, 9:547-550.
12. Sparacio S., Pfeiffer T., Holtkotte D., Bosch V. Inter-retroviral fusion mediated by human immunodeficiency virus or murine leukemia virus glycoproteins: independence of cellular membranes and membrane vesicles. Virology 2002, 294:305-311.
13. Shimizu N., Tanaka A., Mori T., Ohtsuki T., Hoque A., Jinno-Oue A., Apichartpiyakul C., Kusagawa S., Takebe Y., Hoshino H. A formylpeptide receptor, FPRL1, acts as an efficient coreceptor for primary isolates of human immunodeficiency virus. Retrovirology 2008, 5:52.
14. 2-terminal extracellular region of an orphan G protein-coupled receptor, GPR1, preferentially inhibits infection of X4 HIV-1. J. Biol. Chem. 2005, 280:30924-30934.
15. Soda Y., Shimizu N., Jinno A., Liu H.Y., Kanbe K., Kitamura T., Hoshino H. Establishment of a new system for determination of coreceptor usages of HIV based on the human glioma NP-2 cell line. Biochem. Biophys. Res. Commun. 1999, 258:313-321.
16. McAllister R.M., Gardner M.B., Greene A.E., Bradt C., Nichols W.W., Landing B.H. Cultivation in vitro of cells derived from a human osteosarcoma. Cancer 1971, 27:397-402.
17. Bigner D.D., Bigner S.H., Ponten J., Westermark B., Mahaley M.S., Ruoslahti E., Herschman H., Eng L.F., Wikstrand C.J. Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cell lines derived from human gliomas. J. Neuropathol. Exp. Neurol. 1981, 40:201-229.
18. Gey G.O., Coffman W.D., Kubicek M.T. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 1952, 12:264-265.
19. Chesebro B., Buller R., Portis J., Wehrly K. Failure of human immunodeficiency virus entry and infection in CD4-positive human brain and skin cells. J. Virol. 1990, 64:215-221.
20. Kinsella T.M., Nolan G.P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 1996, 7:1405-1413.
21. Hachiya A., Aizawa-Matsuoka S., Tanaka M., Takahashi Y., Ida S., Gatanaga H., Hirabayashi Y., Kojima A., Tatsumi M., Oka S. Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5). Antimicrob. Agents Chemother. 2001, 45:495-501.
22. Hoshino H., Esumi H., Miwa M., Shimoyama M., Minato K., Tobinai K., Hirose M., Watanabe S., Inada N., Kinoshita K., Kamihira S., Ichimaru M., Sugimura T. Establishment and characterization of 10 cell lines derived from patients with adult T-cell leukemia. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:6061-6065.
23. Tokizawa S., Shimizu N., Hui-Yu L., Deyu F., Haraguchi Y., Oite T., Hoshino H. Infection of mesangial cells with HIV and SIV: identification of GPR1 as a coreceptor. Kidney Int. 2000, 58:607-617.
24. Mikulak J., Teichberg S., Faust T., Schmidtmayerova H., Singhal P.C. HIV-1 harboring renal tubular epithelial cell interaction with T cells results in T cell trans-infection. Virology 2009, 385:105-114.
25. Albert J., Fenyo E.M. Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers. J. Clin. Microbiol. 1990, 28:1560-1564.
26. Brinchmann J.E., Albert J., Vartdal F. Few infected CD4+ T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. J. Virol. 1991, 65:2019-2023.
27. Schmidtmayerova H., Alfano M., Nuovo G., Bukrinsky M. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 1998, 72:4633-4642.
28. Borges M., Bose P., Frank H.G., Kaufmann P., Potgens A.J. A two-colour fluorescence assay for the measurement of syncytial fusion between trophoblast-derived cell lines. Placenta 2003, 24:959-964.
29. Liu H.Y., Soda Y., Shimizu N., Haraguchi Y., Jinno A., Takeuchi Y., Hoshino H. CD4-dependent and CD4-independent utilization of coreceptors by human immunodeficiency viruses type 2 and simian immunodeficiency viruses. Virology 2000, 278:276-288.
30. Sakamoto T., Ushijima H., Okitsu S., Suzuki E., Sakai K., Morikawa S., Muller W.E. Establishment of an HIV cell-cell fusion assay by using two genetically modified HeLa cell lines and reporter gene. J. Virol. Methods 2003, 114:159-166.
31. Bagasra O., Lavi E., Bobroski L., Khalili K., Pestaner J.P., Tawadros R., Pomerantz R.J. Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry. AIDS 1996, 10:573-585.
32. Sabri F., Tresoldi E., Di Stefano M., Polo S., Monaco M.C., Verani A., Fiore J.R., Lusso P., Major E., Chiodi F., Scarlatti G. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology 1999, 264:370-384.
33. Nelson J.A., Wiley C.A., Reynolds-Kohler C., Reese C.E., Margaretten W., Levy J.A. Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 1988, 1:259-262.
34. Barbaro G., Di Lorenzo G., Grisorio B., Barbarini G. Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV-positive patients. N. Engl. J. Med. 1998, 339:1093-1099. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS.
35. Housset C., Lamas E., Brechot C. Detection of HIV1 RNA and p24 antigen in HIV1-infected human liver. Res. Virol. 1990, 141:153-159.
36. Geijtenbeek T.B., Kwon D.S., Torensma R., van Vliet S.J., van Duijnhoven G.C., Middel J., Cornelissen I.L., Nottet H.S., KewalRamani V.N., Littman D.R., Figdor C.G., van Kooyk Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
37. He W., Neil S., Kulkarni H., Wright E., Agan B.K., Marconi V.C., Dolan M.J., Weiss R.A., Ahuja S.K. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 2008, 4:52-62.
38. Bobardt M.D., Saphire A.C., Hung H.C., Yu X., Van der Schueren B., Zhang Z., David G., Gallay P.A. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 2003, 18:27-39.
39. Weitzman J.B., Chen A., Hemler M.E. Investigation of the role of beta 1 integrins in cell-cell adhesion. J. Cell Sci. 1995, 108(Pt 11):3635-3644.
40. Kiener H.P., Brenner M.B. Building the synovium: cadherin-11 mediates fibroblast-like synoviocyte cell-to-cell adhesion. Arthritis Res. Ther. 2005, 7:49-54.
41. Laurent-Crawford A.G., Krust B., Riviere Y., Desgranges C., Muller S., Kieny M.P., Dauguet C., Hovanessian A.G. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res. Hum. Retroviruses 1993, 9:761-773.
42. Holm G.H., Zhang C., Gorry P.R., Peden K., Schols D., De Clercq E., Gabuzda D. Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure. J. Virol. 2004, 78:4541-4551.
43. Orenstein J.M. The macrophage in HIV infection. Immunobiology 2001, 204:598-602.
44. Jones M.V., Bell J.E., Nath A. Immunolocalization of HIV envelope gp120 in HIV encephalitis with dementia. AIDS 2000, 14:2709-2713.
45. Scheller C., Jassoy C. Syncytium formation amplifies apoptotic signals: a new view on apoptosis in HIV infection in vitro. Virology 2001, 282:48-55.
46. Gallagher T.M., Buchmeier M.J., Perlman S. Cell receptor-independent infection by a neurotropic murine coronavirus. Virology 1992, 191:517-522.